Table 3.
Patient Characteristics for FV Status
| Characteristic | Total N (%) | FV status | P | ||
|---|---|---|---|---|---|
|
| |||||
| Optimal | Suboptimal | None | |||
| Gender | 0.4137 | ||||
| Male | 227 (55.2) | 30 (13.2) | 118 (52.0) | 79 (34.8) | |
| Female | 184 (44.8) | 32 (17.4) | 96 (52.2) | 56 (30.4) | |
| Race | 0.0675 | ||||
| Black | 48 (11.7) | 5 (10.4) | 29 (60.4) | 14 (29.2) | |
| White | 351 (85.4) | 53 (15.1) | 183 (52.1) | 115 (32.8) | |
| Other | 12 (2.9) | 4 (33.3) | 2 (16.7) | 6 (50.0) | |
| Hospitalization | 0.1561 | ||||
| Yes | 204 (49.6) | 34 (16.7) | 103 (50.5) | 67 (32.8) | |
| No | 207 (50.4) | 28 (13.5) | 111 (53.6) | 68 (32.9) | |
| Mean age* ± SD | 67.3 ± 12.1 | 70.6 ± 10.0 | 68.1 ± 11.5 | 64.6 ± 13.6 | 0.0021 |
| Mean survival time* ± SD | 52.4 ± 50.4 | 57.1 ± 63.7 | 54.2 ± 48.5 | 47.4 ± 46.2 | 0.3564 |
*
Age was measured in years and survival time in months.
FV, influenza vaccination; SD, standard deviation.